Mostra i principali dati dell'item

dc.contributor.authorElexpe, Ane
dc.contributor.authorSánchez Sánchez, Laura
dc.contributor.authorTolentino Cortez, Tarson
dc.contributor.authorAstigarraga, Egoitz
dc.contributor.authorTorrecilla, María
dc.contributor.authorBarreda Gómez, Gabriel
dc.date.accessioned2023-11-02T11:43:41Z
dc.date.available2023-11-02T11:43:41Z
dc.date.issued2022
dc.identifier.citationBiomedicines, 2022, Vol. 10, Nº. 5, 980es
dc.identifier.issn2227-9059es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/62573
dc.descriptionProducción Científicaes
dc.description.abstractDrug side effects are one of the main reasons for treatment withdrawal during clinical trials. Reactive oxygen species formation is involved in many of the drug side effects, mainly by interacting with the components of the cellular respiration. Thus, the early detection of these effects in the drug discovery process is a key aspect for the optimization of pharmacological research. To this end, the superoxide formation of a series of drugs and compounds with antidepressant, antipsychotic, anticholinergic, narcotic, and analgesic properties was evaluated in isolated bovine heart membranes and on cell membrane microarrays from a collection of human tissues, together with specific inhibitors of the mitochondrial electron transport chain. Fluphenazine and PB28 promoted similar effects to those of rotenone, but with lower potency, indicating a direct action on mitochondrial complex I. Moreover, nefazodone, a drug withdrawn from the market due to its mitochondrial hepatotoxic effects, evoked the highest superoxide formation in human liver cell membranes, suggesting the potential of this technology to anticipate adverse effects in preclinical phases.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMicroarrayses
dc.subjectHuman geneticses
dc.subjectGenética humanaes
dc.subjectPsychopharmacologyes
dc.subjectClinical psychologyes
dc.subjectPsychiatryes
dc.subjectAntipsychotic drugses
dc.subjectAntipsicóticoses
dc.subjectDrugses
dc.subjectMedicamentos - Efectos secundarioses
dc.subjectCell membraneses
dc.subjectMembranas celulareses
dc.subjectMitochondrieses
dc.subjectMitocondriases
dc.titleAnalysis of mitochondrial function in cell membranes as indicator of tissue vulnerability to drugs in humanses
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2022 The Authorses
dc.identifier.doi10.3390/biomedicines10050980es
dc.relation.publisherversionhttps://www.mdpi.com/2227-9059/10/5/980es
dc.identifier.publicationfirstpage980es
dc.identifier.publicationissue5es
dc.identifier.publicationtitleBiomedicineses
dc.identifier.publicationvolume10es
dc.peerreviewedSIes
dc.description.projectMinisterio de Economía y Competitividad - (grant DIN2019-010902)es
dc.description.projectGobierno Vasco, Departamento de Desarrollo Económico, Sostenibilidad y Medio Ambiente - (grant Bikaintek: 48-AF-W2-2019-00007)es
dc.identifier.essn2227-9059es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco3209 Farmacologíaes
dc.subject.unesco3211 Psiquiatríaes
dc.subject.unesco6113 Psicofarmacologíaes
dc.subject.unesco3201.05 Psicología Clínicaes


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item